Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "C"

11199 News Found

Teva study shows Huntington’s disease treatment improves life for patients & caregivers
Clinical Trials | June 24, 2026

Teva study shows Huntington’s disease treatment improves life for patients & caregivers

The findings come from the first and only decentralized real-world study examining how HD chorea affects patients and caregivers and how treatment impacts quality of life


Oval & Merck Specialities sign strategic pact to expand access to advanced IVF care in India
News | June 24, 2026

Oval & Merck Specialities sign strategic pact to expand access to advanced IVF care in India

The collaboration comes at a time when access to high-quality fertility treatment remains uneven, despite rapid market expansion


European Commission approves AbbVie's MAVIRET for acute Hepatitis C treatment
Drug Approval | June 24, 2026

European Commission approves AbbVie's MAVIRET for acute Hepatitis C treatment

Approval makes it the first and only therapy in the EU indicated for both acute and chronic hepatitis C, supported by Phase 3 data


Govt seeks stakeholder feedback on proposed changes to GTE exemption list for medical devices
Medical Device | June 24, 2026

Govt seeks stakeholder feedback on proposed changes to GTE exemption list for medical devices

Industry members have until 15 July 2026 to submit feedback on proposals seeking additions, deletions and modifications to the Global Tender Enquiry


Biocon to supply insulin under Malaysia MoH contracts worth over Rs. 515 crore
Biopharma | June 24, 2026

Biocon to supply insulin under Malaysia MoH contracts worth over Rs. 515 crore

Partnership with Duopharma Biotech covers human insulin, insulin glargine and insulin aspart, supporting diabetes care and medicine security in Malaysia


Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development
Biopharma | June 23, 2026

Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development

New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making


KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru
Hospitals | June 23, 2026

KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru

KIMS RENOVA Oncology Institute, in association with the Samrohana Cancer Foundation, announced the “134 Free Screening Camp Pledge”,


Teva submits FDA application for experimental Tourette syndrome treatment ecopipam
Drug Approval | June 23, 2026

Teva submits FDA application for experimental Tourette syndrome treatment ecopipam

The filing is backed by positive Phase 3 results recently published in JAMA Neurology


FDA advisory panel backs Moderna flu vaccine candidate for older adults
News | June 23, 2026

FDA advisory panel backs Moderna flu vaccine candidate for older adults

The backing comes as influenza remains a persistent public health burden


FDA clears 131 drugs as global pharma approval momentum rebounds in 2025
News | June 23, 2026

FDA clears 131 drugs as global pharma approval momentum rebounds in 2025

After a volatile decade in which approvals swung sharply from year to year, 2025’s total pushed past long-term norms, exceeding the 10-year average